NEW YORK--(BUSINESS WIRE)--Rasna Therapeutics, Inc. (OTCQB: RASP), a development stage biotechnology company focused on the development of cancer drugs, today announced the appointment of Dr Alessandro Padova as Chairman with immediate effect.
“We are delighted to welcome Alessandro to the Rasna team and look forward to the positive contribution of his leadership, experience and successful international track record of progressing assets through clinical development,” commented Jim Tripp, CEO of Rasna.
